NCODA Logo

Managing Immunotherapy Treatment Related Rash

Written by: Natasha Heimbigner, PharmD, Summit Cancer Centers Download Here Description of PQI: The use of immunotherapy in cancer treatment has expanded tremendously over the last several years. The most common adverse effects include dermatologic, gastrointestinal,...

Tucatinib (Tukysa®) Management

Written by: Katie Carter, PharmD, BCPS, IU Simon Cancer Center Download Here Description: The purpose of this PQI is to highlight tucatinib and its usage and management in advanced unresectable or metastatic HER2-positive breast cancer who have received one or more...